RADIOLOGICAL OR NUCLEAR MEDICAL COUNTERMEASURE PRODUCT DEVELOPMENT SUPPORT (PDS)
Please see the attached PDF for the solicitation notice (75N93026R00005)
RADIOLOGICAL OR NUCLEAR MEDICAL COUNTERMEASURE PRODUCT DEVELOPMENT SUPPORT (PDS)
The National Institute of Allergy and Infectious Diseases (NIAID) seeks a contractor to advance candidate medical countermeasures (MCMs) for acute radiation syndrome and delayed effects of acute radiation exposure toward FDA approval. The contract will be a single Indefinite Delivery, Indefinite Quantity (IDIQ) type award with a 7-year period of performance beginning on or about July 1, 2027. Task areas include administrative support, animal model development, efficacy testing, non-clinical studies, chemistry/manufacturing/control support, and Phase I clinical studies. Performance location is not specified. No budget amount is provided.